ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,579Medicare Part D Prescriptions Filled, Including Refills

Rank: 60 out of 1802

$679K Total Retail Price of All Prescriptions

Rank: 30 out of 1802

534 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 534 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 534 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 8,009 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
SIMVASTATIN 468 363 1 1
LEVOTHYROXINE SODIUM 421 326 2 2
OMEPRAZOLE 377 302 3 4
HYDROCODONE-ACETAMINOPHEN 367 238 S3 4 10
FUROSEMIDE 359 310 5 5
WARFARIN SODIUM 242 215 6 7
AMLODIPINE BESYLATE 234 202 7 6
LISINOPRIL 229 190 8 3
PRAVASTATIN SODIUM 225 203 9 19
TRIAMTERENE-HCTZ 174 143 10 49
METFORMIN HCL ER 147 92 11 46
CITALOPRAM HBR 141 112 12 17
ZOLPIDEM TARTRATE 133 89 13 27
GLIMEPIRIDE 129 108 14 42
LOSARTAN POTASSIUM 128 110 15 18
POTASSIUM CHLORIDE 128 99 15 15
ADVAIR DISKUS 127 60 17 32
ATENOLOL 127 115 17 12
METOPROLOL TARTRATE 122 98 19 9
PREDNISONE 119 88 20 33
PANTOPRAZOLE SODIUM 106 82 21 44
METOPROLOL SUCCINATE 103 87 22 13
LANTUS 98 36 23 47
CLOPIDOGREL 95 82 24 48
CARVEDILOL 89 68 25 36
AZITHROMYCIN 89 64 25 65
ATORVASTATIN CALCIUM 89 71 25 14
METFORMIN HCL 87 66 28 11
DONEPEZIL HCL 79 75 29 26
ALPRAZOLAM 79 58 29 228
HYDROCHLOROTHIAZIDE 78 55 31 8
PAROXETINE HCL 75 60 32 60
GABAPENTIN 74 46 33 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 73 61 34 23
TAMSULOSIN HCL 73 61 34 28
POLYETHYLENE GLYCOL 3350 71 42 36 29
NEXIUM 69 45 37 50
CRESTOR 67 54 38 31
DIGOXIN 67 66 38 45
HYDRALAZINE HCL 64 36 40 119
NAMENDA 64 52 40 34
LOSARTAN-HYDROCHLOROTHIAZIDE 63 51 42 52
TRAMADOL HCL 59 32 43 22
FLUTICASONE PROPIONATE 58 27 44 37
LANTUS SOLOSTAR 58 29 44 63
OXYBUTYNIN CHLORIDE ER 56 30 46 99
PLAVIX 56 47 46 81
INSULIN SYRINGE 55 34 48 157
PROAIR HFA 53 27 49 58
ALLOPURINOL 52 39 50 24
TRIAMCINOLONE ACETONIDE 51 39 51 91
VENLAFAXINE HCL ER 51 37 51 73
OXYCODONE-ACETAMINOPHEN 50 28 S2 53 67
VENTOLIN HFA 50 32 53 125
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.